|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT02930330 |
|
Date of registration:
|
07/10/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Interval Training in Cardiac Rehabilitation
|
|
Scientific title:
|
Interval Training in Cardiac Rehabilitation: Effects on Cardiorespiratory Fitness and Platelet Function - A Randomized Controlled Trial |
|
Date of first enrolment:
|
October 2015 |
|
Target sample size:
|
82 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02930330 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Austria
| | | | | | | |
|
Contacts
|
|
Name:
|
Stefan Heber, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Medical University of Vienna |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- No regular exercise training within the last 6 months
- Dual anti-platelet therapy (low-dose aspirin plus ADP(adenosine diphosphate)-receptor
antagonist)
- Status post percutaneous coronary intervention after recent acute coronary syndrome as
underlying reason for current rehabilitation
- Eligibility for outpatient cardiac rehabilitation according to Table I in Niebauer et
al. 2013 (PMID: 22508693)
Exclusion Criteria:
- Type II diabetes mellitus
- Aortic aneurysm / dissection
- Uncontrolled hypertension (>180/110 mmHg)
- Pulmonary hypertension (>55 mmHg)
- Previously known hereditary platelet disorders
- Disorders of plasmatic coagulation
- Anemia (Hb < 13g/dl)
- History of end-stage liver or kidney disease
Age minimum:
45 Years
Age maximum:
N/A
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Atherosclerosis
|
|
Coronary Artery Disease
|
|
Intervention(s)
|
|
Behavioral: INT
|
|
Behavioral: CONT
|
|
Primary Outcome(s)
|
|
Platelet reactivity at physical rest: EC50 of TRAP-6 in terms of platelet CD62P expression. Unit of Measure: µM (Micromolar)
[Time Frame: 6 weeks]
|
|
Secondary Outcome(s)
|
|
Cardiorespiratory fitness: Maximal oxygen consumption
[Time Frame: 12 weeks]
|
|
Platelet reactivity at physical rest: EC50 of TRAP-6 in terms of platelet CD62P expression. Unit of Measure: µM
[Time Frame: 12 weeks]
|
|
Cardiorespiratory fitness: Maximal power output
[Time Frame: 12 weeks]
|
|
Cardiorespiratory fitness: Maximal oxygen consumption
[Time Frame: 6 weeks]
|
|
Cardiorespiratory fitness: Maximal power output
[Time Frame: 6 weeks]
|
|
Secondary ID(s)
|
|
Heber 15136
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|